(Q53255022)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480230%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Development of metastatic HER2(+) breast cancer is independent of the adaptive immune system (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480230%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

main subject

adaptive immune system

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480230%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Chris W Doornebal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480230%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Metamia Ciampricotti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480230%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Kim Vrijland

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480230%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Cheei-Sing Hau

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480230%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Ewoud N Speksnijder

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480230%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Katharina Wartha

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480230%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Jos Jonkers

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480230%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Karin E de Visser

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480230%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

17 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480230%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480230%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

224

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480230%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480230%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

56-66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21480230%20AND%20SRC:MED&resulttype=core&format=json

The immunobiology of cancer immunosurveillance and immunoediting

28 January 2020

cites work

1 reference

Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance.

21 January 2018

1 reference

Paradoxical roles of the immune system during cancer development

21 January 2018

1 reference

Does the immune system see tumors as foreign or self?

21 January 2018

1 reference

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

21 January 2018

1 reference

De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent

21 January 2018

1 reference

A lymphotoxin-driven pathway to hepatocellular carcinoma

21 January 2018

1 reference

CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages

21 January 2018

1 reference

FcRgamma activation regulates inflammation-associated squamous carcinogenesis.

21 January 2018

1 reference

Molecular portraits of human breast tumours

21 January 2018

1 reference

Clinical relevance of the triple-negative breast cancer concept: genetic basis and clinical utility of the concept

21 January 2018

1 reference

The distinctive nature of HER2-positive breast cancers

21 January 2018

1 reference

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates

21 January 2018

1 reference

T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

21 January 2018

1 reference

Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future

21 January 2018

1 reference

Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene

21 January 2018

1 reference

Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice.

21 January 2018

1 reference

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

21 January 2018

1 reference

The interface between innate and adaptive immunity

21 January 2018

1 reference

Adaptive control of innate immunity

21 January 2018

1 reference

Cytokines and their relationship to the symptoms and outcome of cancer.

21 January 2018

1 reference

Spontaneous immune responses to sporadic tumors: tumor-promoting, tumor-protective or both?

21 January 2018

1 reference

Anti-HER-2/neu immune responses are induced before the development of clinical tumors but declined following tumorigenesis in HER-2/neu transgenic mice

21 January 2018

1 reference

Danger signals and nonself entity of tumor antigen are both required for eliciting effective immune responses against HER-2/neu positive mammary carcinoma: implications for vaccine design

21 January 2018

1 reference

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

21 January 2018

1 reference

Natural immunosurveillance against spontaneous, autochthonous breast cancers revealed and enhanced by blockade of IL-13-mediated negative regulation.

21 January 2018

1 reference

Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity

21 January 2018

1 reference

Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance

21 January 2018

1 reference

Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism.

21 January 2018

1 reference

DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice.

21 January 2018

1 reference

Immunological inhibition of carcinogenesis

21 January 2018

1 reference

Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacy.

21 January 2018

1 reference

The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity

21 January 2018

1 reference

The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta

21 January 2018

1 reference

Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors

21 January 2018

1 reference

Untangling the ErbB signalling network

21 January 2018

1 reference

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

21 January 2018

1 reference

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

21 January 2018

1 reference

Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.

21 January 2018

1 reference

Maximizing mouse cancer models

21 January 2018

1 reference